Nicox S.A. (OTCMKTS:NICXF) crossed below its 50 day moving average during trading on Wednesday . The stock has a 50 day moving average of $5.30 and traded as low as $5.12. Nicox shares last traded at $5.15, with a volume of 3,600 shares changing hands.
Separately, Zacks Investment Research upgraded shares of Nicox from a “sell” rating to a “hold” rating in a research report on Wednesday, March 24th.
The firm’s 50-day moving average price is $5.30 and its 200 day moving average price is $5.27. The company has a market capitalization of $172.37 million, a price-to-earnings ratio of -7.46 and a beta of 0.88.
Nicox SA, an ophthalmology company, develops solutions to maintain ocular health in France and internationally. It offers VYZULTA, a latanoprostene bunod ophthalmic solution for open angle glaucoma or ocular hypertension; ZERVIATE, a cetirizine ophthalmic solution for the treatment of ocular itching associated with allergic conjunctivitis; and NCX 4280, an ophthalmic solution that targets morning eye congestion.
Read More: EV Stocks
Receive News & Ratings for Nicox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nicox and related companies with MarketBeat.com's FREE daily email newsletter.